A hostile takeover is an acquisition that moves forward over the objection of the target company’s board. Instead of negotiating with the directors, the acquiring company goes around them, appealing straight to shareholders to sell their stock or hand over their votes. These fights can last months, involve billions of dollars, and end with one company swallowing another whose leadership fought the deal every step of the way.
How a Hostile Bid Differs From a Friendly Deal
In a friendly acquisition, the two boards negotiate a price, agree on terms, and jointly recommend the deal to shareholders. The process is cooperative from start to finish. A hostile bid begins when the target’s board says no and the acquirer decides to press ahead anyway.
That distinction changes everything about how the deal unfolds. In a friendly deal, the board negotiates on behalf of shareholders to extract the best price. In a hostile bid, the board is actively fighting the deal, and shareholders have to decide for themselves whether to accept the offer. The acquirer’s job is convincing enough individual shareholders that the deal is worth taking even though the people running the company insist otherwise.
Board opposition isn’t always about price. Sometimes management genuinely believes the company is worth more independent. Other times, executives are protecting their own positions. Shareholders have to sort those motivations out on their own, which is why federal securities law loads both sides with disclosure obligations.
How the Acquirer Attacks
An acquirer locked out of the boardroom has a limited set of moves. Each one targets shareholders directly, either by buying their stock or by winning the right to vote it.
Tender Offers
The most direct route is a tender offer: a public bid to purchase shares from any willing shareholder, usually at a premium over the current trading price. If the stock is trading at $50, the acquirer might offer $65 or $70 to make selling an easy call. The offer is typically conditioned on enough shareholders tendering to give the acquirer a controlling stake. If the minimum isn’t hit, the acquirer can withdraw the bid.
This puts the board in an uncomfortable spot. Shareholders see a clear, immediate gain on the table, and the board has to justify why they should turn it down. A premium of 20 to 40 percent above market is common, and against that kind of return, arguments about “long-term value” can ring hollow.
Proxy Fights
A proxy fight takes a different route. Instead of buying shares, the acquirer asks shareholders to hand over their voting authority. The goal is to win enough votes at the next annual meeting to replace the board with directors who support the deal. Once those directors are seated, they approve the acquisition from the inside, turning a hostile bid into a board-approved transaction.
Proxy fights are cheaper than tender offers because the acquirer isn’t writing checks for stock. They also take longer and require winning a persuasion campaign against a board that controls the company’s communication channels and shareholder lists. Anyone soliciting proxies must file disclosure documents with the Securities and Exchange Commission before contacting shareholders.1eCFR. 17 CFR Part 240 Subpart A – Regulation 14A: Solicitation of Proxies
Toehold Acquisitions
Before launching a formal bid, an acquirer often quietly accumulates a small block of the target’s stock on the open market. Keeping the stake below 5 percent avoids the federal disclosure that would tip off the market and the board. Even a small position lowers the acquirer’s average cost if the deal eventually closes at a premium, and it gives the buyer legal standing to sue the target’s directors if the sale process goes sideways.
If another bidder wins the target with a higher offer, the toehold still generates a profit. The acquirer collects the deal premium on shares bought at the lower pre-bid price, which can offset the cost of a failed campaign.
Two-Tier Tender Offers
A two-tier offer adds pressure by splitting the purchase into two stages at different prices. The first tier offers a higher price, usually cash, for enough shares to gain majority control. The second tier offers a lower price, often in securities rather than cash, for the remaining shares. Shareholders who don’t tender in the first round risk getting stuck with the lower back-end price.2SEC.gov. Two-Tier Tender Offers: A Mythectomy
The structure creates a prisoner’s dilemma. Even shareholders who would prefer the company stay independent may feel compelled to tender early to avoid being squeezed. Critics call the tactic coercive, and regulators have long scrutinized these bids for exactly that reason.
How the Target Defends
Target boards have built up an arsenal of defenses, many of them adopted years before any specific threat appears. The most effective ones make the acquisition either prohibitively expensive or structurally impossible without board cooperation.
Poison Pill
The poison pill, formally called a shareholder rights plan, is the most common defense. It grants existing shareholders the right to buy additional shares at a steep discount once any outside buyer crosses a preset ownership threshold, usually between 10 and 20 percent. The hostile bidder is excluded from the discount.
When the pill triggers, the flood of new discounted shares dilutes the acquirer’s stake and drives up the cost of gaining control. A bidder who owned 15 percent might suddenly own 8 percent after the dilution. The practical effect is that no hostile buyer can gain control without negotiating with the board to have the pill removed, which gives directors leverage even against a generous offer.
White Knight
When a hostile bid lands, the target board may go looking for a friendlier buyer. The “white knight” typically offers a price at or above the hostile bid, giving shareholders a financially competitive alternative while letting management negotiate favorable terms on things like retention, headquarters location, or operational strategy.
The board walks a tightrope. If it steers the company to a white knight at a lower price simply because management likes the buyer better, it risks breaching its fiduciary duty to shareholders. Competing offers have to stand on their financial merits.
Staggered Board
A staggered board divides directors into classes, typically three, with only one class up for election each year. An acquirer who wins a proxy fight replaces only a third of the board and still faces a hostile majority. Gaining full control requires winning two consecutive annual elections, stretching the takeover timeline to two years or more.
The delay is the point. It gives the target time to develop alternatives, find a white knight, or make the case that its independent strategy beats the hostile offer. Combined with a poison pill, a staggered board is a formidable barrier: the acquirer can’t remove the pill without controlling the board, and it can’t control the board for years.
Greenmail
Greenmail is corporate extortion in reverse. A hostile buyer accumulates a large block of stock and threatens a takeover unless the target buys the shares back at a premium. The target pays the ransom and the threat disappears. Congress took a dim view of the practice and imposed a 50 percent excise tax on any profit from a greenmail payment, which has made the strategy far less attractive since the late 1980s.3Office of the Law Revision Counsel. 26 US Code 5881 – Greenmail
The tax applies only when the shareholder held the stock for less than two years, threatened or made a tender offer during that period, and received a buyback offer that wasn’t extended to all shareholders on the same terms.3Office of the Law Revision Counsel. 26 US Code 5881 – Greenmail
Pac-Man Defense
The Pac-Man defense is exactly what it sounds like. The target turns around and launches its own hostile bid for the acquirer. If the target can pick up enough shares or board seats in the acquirer, the original bid collapses under the mutual entanglement. This is a desperation move that requires the target to have the resources to credibly threaten a counter-acquisition, so it’s limited to situations where the two companies are roughly comparable in size. It almost never gets past the threat stage.
Crown Jewel Defense
A target can also remove the motivation for the takeover by selling off the assets the acquirer actually wants. If a hostile buyer is after a company’s pharmaceutical patents or its retail chain, the target sells those assets to a friendly third party, sometimes with an agreement to buy them back later if the hostile bid fails. It’s a scorched-earth move that damages the target’s own value, so boards treat it as a last resort.
Hostile Takeover Examples
The mechanics play out differently in every deal. A few well-known battles show how these strategies interact in practice.
Oracle and PeopleSoft, 2003 to 2004
Oracle launched an unsolicited cash tender offer for enterprise software rival PeopleSoft in June 2003 at $16 per share. PeopleSoft’s board rejected the bid and deployed a poison pill, but Oracle refused to walk away. PeopleSoft also introduced a Customer Assurance Program promising customers up to five times their money back if Oracle acquired the company and reduced product support. The fight dragged on for 18 months. Oracle repeatedly raised its offer, closing the deal in December 2004 at $26.50 per share, more than 65 percent above the original bid. A determined acquirer with deep pockets can outlast defensive measures if it keeps sweetening the price.
Kraft Foods and Cadbury, 2009 to 2010
Kraft Foods launched a hostile bid for British confectionery company Cadbury in late 2009. Cadbury’s board called the initial offer of 745 pence per share “unattractive” and publicly stated it would have preferred almost any other buyer. Cadbury’s chairman assembled an advisory team and lobbied the British government for support. The defense held until January 2010, when Kraft raised its offer to 840 pence per share plus a special dividend. At that price, 72 percent of Cadbury’s shareholders accepted the deal, valuing the acquisition at roughly £11.9 billion. Even a well-organized defense yields when the price climbs high enough.
Sanofi-Aventis and Genzyme, 2010
French pharmaceutical company Sanofi launched a hostile bid for biotechnology firm Genzyme in 2010. Genzyme’s board rejected the initial offer, arguing it undervalued the company’s pipeline. Sanofi persisted and eventually raised its bid significantly, closing the deal at approximately $24.5 billion. The pattern is familiar in pharmaceutical takeovers: the target’s board holds out for a better price, and the acquirer pays up because the drug portfolio is worth more than the premium.
Elon Musk and Twitter, 2022
After disclosing a 9.2 percent stake in Twitter, Elon Musk made an unsolicited offer to buy the entire company for $54.20 per share. Twitter’s board immediately adopted a poison pill to keep Musk from accumulating more shares. Ten days later, the board reversed course and accepted the offer, valuing the company at roughly $44 billion. When Musk tried to back out, Twitter sued in Delaware’s Court of Chancery to force the deal through, and Musk completed the acquisition in October 2022. The poison pill collapsed almost immediately once the board concluded the price was genuinely favorable to shareholders.
How Hostile Bids Are Financed
Hostile bids for large public companies routinely run into the billions, and the acquirer rarely writes a check from cash on hand. Most large deals rely heavily on debt. In a leveraged structure, the acquirer borrows a substantial share of the purchase price, often using the target’s own assets or cash flows as collateral.
The wave of large hostile bids in the 1980s was driven in significant part by the development of high-yield debt instruments, commonly called junk bonds, which gave bidders access to enormous pools of capital that hadn’t previously been available for hostile transactions. Today’s deals typically mix committed bank financing, bridge loans, and sometimes bond offerings. The financing package is a critical piece of any tender offer, because shareholders are far more likely to tender if the acquirer can prove the money is actually there.
Federal Rules That Shape the Fight
Federal securities and antitrust law impose disclosure and timing obligations on both sides. These rules exist to keep shareholders from being pressured into decisions without enough information.
The Williams Act and Schedule 13D
The Williams Act, enacted in 1968, requires any person or group that acquires more than 5 percent of a public company’s stock to file a disclosure statement known as Schedule 13D with the SEC.4Office of the Law Revision Counsel. 15 US Code 78n – Proxies The filing has to disclose who the buyer is, where the money came from, and whether the buyer intends to seek control.
The original filing deadline was 10 calendar days after crossing the 5 percent threshold. The SEC shortened it to five business days under amendments that took effect in 2024.5SEC.gov. SEC Adopts Amendments to Rules Governing Beneficial Ownership Reporting The shorter window was designed to cut down on the stock an acquirer could quietly accumulate before the market caught on. Before the change, aggressive buyers routinely used the full 10 days to build positions well above 5 percent before anyone knew.
Tender Offer Timing
Once a tender offer is launched, federal rules require it to stay open for at least 20 business days. This cooling-off period gives shareholders time to evaluate the offer, review any competing bids, and hear the board’s response. If the acquirer changes the price or other material terms, the clock can reset. The timing rules prevent an acquirer from using artificial urgency to stampede shareholders into tendering before they understand the deal.
Antitrust Review
Large acquisitions have to clear antitrust review before closing. The Hart-Scott-Rodino Act requires both parties to file premerger notification with the Federal Trade Commission and the Department of Justice when the transaction exceeds certain dollar thresholds. For 2026, the minimum size-of-transaction threshold triggering a mandatory filing is $133.9 million.6Federal Trade Commission. New HSR Thresholds and Filing Fees for 2026
After filing, a waiting period has to expire before the deal can close. For cash tender offers that period is 15 days, shorter than the 30-day period for other transactions. If regulators want to investigate further, they can issue a “second request” for more information, extending the waiting period by up to 10 additional days for a cash tender offer after all requested documents are provided.7Office of the Law Revision Counsel. 15 US Code 18a – Premerger Notification and Waiting Period
How Far the Board Can Go: Fiduciary Duty
State corporate law governs the most important question in any hostile takeover: how far can the board go to block a deal shareholders might want? Because most large U.S. public companies are incorporated in Delaware, Delaware court decisions set the practical standard.
When a board deploys defensive measures against a hostile bid, courts apply heightened scrutiny. Under the framework established in the Unocal case, directors have to show two things. First, they had reasonable grounds to believe the hostile bid posed a genuine threat to the company or its shareholders. Second, the defensive response was proportionate to that threat and didn’t completely shut down the shareholders’ ability to consider the offer.
When the board has decided to sell the company, either to a white knight or through some other transaction, a different standard takes over. The Revlon duty requires the board to shift its focus entirely to getting the highest price reasonably available for shareholders. Defensive measures aimed at keeping the company independent are no longer justifiable at that point. The board becomes an auctioneer, not a gatekeeper. Directors who play favorites or block higher competing bids at this stage face serious liability.
Shareholders who oppose a completed merger aren’t entirely out of options. Appraisal rights allow dissenting shareholders to petition a court to determine the fair value of their shares, which may be higher or lower than the deal price. To preserve the right, a shareholder must not vote in favor of the merger and must submit a written demand for appraisal before the shareholder vote.
What the Deal Costs Shareholders and Executives at Tax Time
Shareholders who tender their stock in a cash acquisition generally realize a taxable gain or loss. Stock held more than a year is taxed at long-term capital gains rates. Stock held a year or less is taxed as short-term gain at ordinary income rates. The math is straightforward, but the check can arrive faster than expected, and estimated tax payments may be necessary to avoid penalties.
Executives face a different issue. When a change in corporate control triggers large severance packages or accelerated stock options, those payments can fall under the golden parachute rules. If an executive’s total payout exceeds three times their average annual compensation over the previous five years, the excess is hit with a 20 percent excise tax on top of regular income taxes.8eCFR. 26 CFR 1.280G-1 – Golden Parachute Payments The company also loses its tax deduction for the excess, making the payments expensive on both sides.